Immune checkpoint blockade works by inhibiting checkpoint proteins, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death-1 (PD-1)/PD-L1, which normally act as brakes on the immune response to prevent excessive activation and autoimmunity [40,41]. The gene discussed is CTLA4; the disease is Autoimmunity.